MétaCan
Menu
Back to cohort
Record W4415422698 · doi:10.1016/j.bglo.2025.100036

Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050

2025· article· en· W4415422698 on OpenAlexaff
Alessandro Hammond, Sruthi Ranganathan, Urvish Jain, Bhav Jain, Puneeth Iyengar, Erin Jay G. Feliciano, Nishwant Swami, James Fan Wu, Aju Mathew, C.S. Pramesh, Edward Christopher Dee, Freddie Bray, Manju Sengar

Bibliographic record

VenueBlood Global Hematology · 2025
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicEconomic and Financial Impacts of Cancer
Canadian institutionsQueen's University
FundersNational Institutes of HealthNational Cancer InstituteProstate Cancer Foundation
KeywordsIncidence (geometry)Mortality rateMultiple myelomaPopulationCancerRelative survivalLymphoma

Abstract

fetched live from OpenAlex

1 Hematologic malignancies in the SAARC region pose a growing burden, with incidence and mortality varying across countries 2 Disparities in healthcare infrastructure contribute to high mortality-to-incidence ratios, and require regionally tailored strategies South Asia, comprising the SAARC nations, bears a disproportionately high cancer mortality relative to incidence. Hematologic malignancies, though potentially curable with timely diagnosis and treatment, remain understudied in this region. We examined the burden, distribution, and future projections of hematologic cancers across SAARC countries to inform equitable cancer control strategies. We used GLOBOCAN 2022 data from the Global Cancer Observatory and UN population estimates to assess incidence and mortality for non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), leukemia, and multiple myeloma across SAARC countries. We report age-standardised incidence and mortality rates (ASIR/ASMR) per 100,000, and mortality-to-incidence ratios (MIRs). Future projections to 2045 were estimated under constant rate assumptions. In 2022, 148,312 hematologic cancers were diagnosed in the SAARC region, including 63,448 cases of leukemia, 52,363 cases of NHLs, 19,922 cases of multiple myeloma, and 12,579 cases of Hodgkin lymphoma. India accounted for over three-quarters of all cases, followed by Pakistan. In terms of age-standardized incidence rates, leukemia was the most common subtype, with highest ASIR in Maldives (6.7 per 100,000 males) and highest ASMR in Pakistan (3.4 per 100,000). In 2022, 30582 deaths from NHL, 4645 deaths from Hodgkin’s lymphoma, 17199 deaths from multiple myeloma, and 46671 deaths from leukemia occurred in SAARC. MIRs ranged widely, from 0.52 (Sri Lanka, NHL) to 1.0 (Bhutan, multiple myeloma). By 2045, 236,000 new cases and 163,149 deaths are projected, with India bearing the greatest burden. Substantial disparities in diagnostic access and healthcare infrastructure persist.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.059
Threshold uncertainty score0.116

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.283
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBlood Global HematologySame topicEconomic and Financial Impacts of CancerFrench-language works237,207